Although cancer will touch nearly every Minnesotan—either directly through a diagnosis or indirectly through a loved one—access to cancer clinical trials is challenging for many across the state.
The Minnesota Cancer Clinical Trials Network (MCCTN), a new state-funded partnership between the U and the state’s major health systems, aims to address these barriers by giving more Minnesotans access to potentially lifesaving therapies.
Viewed by Minnesota Masonic Charities as a critical program for Greater Minnesota, the MCCTN will create new clinical trial sites throughout the state, starting with 18 locations in 2018 and expanding to additional sites in future years.
The first 18 locations include: Aitkin, Albert Lea, Austin, Cambridge, Deer River, Detroit Lakes, Fosston, Grand Rapids, Hastings, Hibbing (two sites), Mankato, Monticello, Park Rapids, Princeton, Thief River Falls, Virginia, and Worthington.
The MCCTN is a collaboration between the Masonic Cancer Center, University of Minnesota; Essentia Health Community Oncology Research Program; Fairview Health Services; the Hormel Institute; Mayo Clinic Cancer Center; Metro-Minnesota Community Oncology Research Consortium; and Sanford Community Oncology Program of the North Central Plains. In addition to the University of Minnesota, trials will originate from Mayo Clinic and the Hormel Institute.
“This initiative fuels research that addresses a pressing challenge—access to world-class cancer care for Minnesotans in every corner of the state,” says Eric Kaler, president of the University of Minnesota.
Learn more about the Minnesota Cancer Clinical Trials Network.
Find a clinical trial that’s underway.